<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cereb Blood Flow Metab</journal-id><journal-id journal-id-type="iso-abbrev">J Cereb Blood Flow Metab</journal-id><journal-id journal-id-type="pmc-domain-id">1259</journal-id><journal-id journal-id-type="pmc-domain">jcbfm</journal-id><journal-id journal-id-type="publisher-id">JCB</journal-id><journal-title-group><journal-title>Journal of Cerebral Blood Flow &amp; Metabolism</journal-title></journal-title-group><issn pub-type="ppub">0271-678X</issn><issn pub-type="epub">1559-7016</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9903216</article-id><article-id pub-id-type="pmcid-ver">PMC9903216.1</article-id><article-id pub-id-type="pmcaid">9903216</article-id><article-id pub-id-type="pmcaiid">9903216</article-id><article-id pub-id-type="pmid">36300327</article-id><article-id pub-id-type="doi">10.1177/0271678X221135658</article-id><article-id pub-id-type="publisher-id">10.1177_0271678X221135658</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Retinal capillary microvessel morphology changes are associated with
vascular damage and dysfunction in cerebral small vessel disease</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6739-5797</contrib-id><name name-style="western"><surname>Wiseman</surname><given-names initials="SJ">Stewart J</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff2-0271678X221135658" ref-type="aff">2</xref><xref rid="aff3-0271678X221135658" ref-type="aff">3</xref><xref rid="fn1-0271678X221135658" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="JF">Jun-Fang</given-names></name><xref rid="aff4-0271678X221135658" ref-type="aff">4</xref><xref rid="fn1-0271678X221135658" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2816-4707</contrib-id><name name-style="western"><surname>Gray</surname><given-names initials="C">Calum</given-names></name><xref rid="aff3-0271678X221135658" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hamid</surname><given-names initials="C">Charlene</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff3-0271678X221135658" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Valdés Hernández</surname><given-names initials="MDC">Maria del C</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff2-0271678X221135658" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ballerini</surname><given-names initials="L">Lucia</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff2-0271678X221135658" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thrippleton</surname><given-names initials="MJ">Michael J</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff2-0271678X221135658" ref-type="aff">2</xref><xref rid="aff3-0271678X221135658" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Manning</surname><given-names initials="C">Cameron</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3811-4439</contrib-id><name name-style="western"><surname>Stringer</surname><given-names initials="M">Michael</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff2-0271678X221135658" ref-type="aff">2</xref><xref rid="aff3-0271678X221135658" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sleight</surname><given-names initials="E">Emilie</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff2-0271678X221135658" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Muñoz Maniega</surname><given-names initials="S">Susana</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morgan</surname><given-names initials="A">Alasdair</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cheng</surname><given-names initials="Y">Yajun</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff5-0271678X221135658" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2424-7123</contrib-id><name name-style="western"><surname>Arteaga</surname><given-names initials="C">Carmen</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jaime Garcia</surname><given-names initials="D">Dany</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Clancy</surname><given-names initials="U">Una</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Doubal</surname><given-names initials="FN">Fergus N</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dhillon</surname><given-names initials="B">Baljean</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff6-0271678X221135658" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>MacGillivray</surname><given-names initials="T">Tom</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff3-0271678X221135658" ref-type="aff">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wu</surname><given-names initials="YC">Yun-Cheng</given-names></name><xref rid="aff4-0271678X221135658" ref-type="aff">4</xref><xref rid="corresp2-0271678X221135658" ref-type="corresp"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9812-6642</contrib-id><name name-style="western"><surname>Wardlaw</surname><given-names initials="JM">Joanna M</given-names></name><xref rid="aff1-0271678X221135658" ref-type="aff">1</xref><xref rid="aff2-0271678X221135658" ref-type="aff">2</xref><xref rid="aff3-0271678X221135658" ref-type="aff">3</xref><xref rid="corresp1-0271678X221135658" ref-type="corresp"/></contrib><aff id="aff1-0271678X221135658">
<label>1</label>Centre for Clinical Brain Sciences, University of Edinburgh,
Edinburgh, UK</aff><aff id="aff2-0271678X221135658">
<label>2</label>UK Dementia Research Institute, University of Edinburgh,
Edinburgh, UK</aff><aff id="aff3-0271678X221135658">
<label>3</label>Edinburgh Imaging Facilities, Edinburgh Imaging, University of
Edinburgh, UK</aff><aff id="aff4-0271678X221135658">
<label>4</label>Department of Neurology, Shanghai General Hospital, Shanghai
Jiao Tong University School of Medicine, Shanghai, China</aff><aff id="aff5-0271678X221135658">
<label>5</label>Department of Neurology, West China Hospital, Sichuan
University, Chengdu, China</aff><aff id="aff6-0271678X221135658">
<label>6</label>NHS Lothian Princess Alexandra Eye Pavilion, UK</aff></contrib-group><author-notes><fn fn-type="equal" id="fn1-0271678X221135658"><label>*</label><p>These authors contributed equally to this work.</p></fn><corresp id="corresp1-0271678X221135658">Joanna M Wardlaw, CCBS, Chancellor’s
Building, Royal Infirmary of Edinburgh, 49 Little France Crescent, Edinburgh,
EH16 4SB, UK. Email: <email>Joanna.Wardlaw@ed.ac.uk</email></corresp><corresp id="corresp2-0271678X221135658">Yun-Cheng Wu, Department of Neurology,
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,
Shanghai 200080, P.R. China. Email:
<email>yunchw@medmail.com.cn</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2023</year></pub-date><volume>43</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">428389</issue-id><fpage>231</fpage><lpage>240</lpage><history><date date-type="received"><day>15</day><month>4</month><year>2022</year></date><date date-type="rev-recd"><day>5</day><month>9</month><year>2022</year></date><date date-type="accepted"><day>6</day><month>9</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>10</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>08</day><month>02</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-24 19:25:36.720"><day>24</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>© The Author(s) 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder content-type="society">International Society for Cerebral Blood
Flow and Metabolism</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons
Attribution 4.0 License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>) which permits
any use, reproduction and distribution of the work without further
permission provided the original work is attributed as specified on the SAGE
and Open Access pages (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_0271678X221135658.pdf"/><abstract><p>Cerebral small vessel disease (SVD) is a cause of stroke and dementia. Retinal
capillary microvessels revealed by optical coherence tomography angiography
(OCTA) are developmentally related to brain microvessels. We quantified retinal
vessel density (VD) and branching complexity, investigating relationships with
SVD lesions, white matter integrity on diffusion tensor imaging (DTI) and
cerebrovascular reactivity (CVR) to CO<sub>2</sub> in patients with minor
stroke. We enrolled 123 patients (mean age 68.1 ± SD 9.9 years), 115 contributed
retinal data. Right (R) and left (L) eyes are reported. After adjusting for age,
eye disease, diabetes, blood pressure and image quality, lower VD remained
associated with higher mean diffusivity (MD) (standardized β; R −0.16 [95%CI
−0.32 to −0.01]) and lower CVR (L 0.17 [0.03 to 0.31] and R 0.19 [0.02 to 0.36])
in normal appearing white matter (NAWM). Sparser branching remained associated
with sub-visible white matter damage shown by higher MD (R −0.24 [−0.08 to
−0.40]), lower fractional anisotropy (FA) (L 0.17 [0.01 to 0.33]), and lower CVR
(R 0.20 [0.02 to 0.38]) in NAWM. OCTA-derived metrics provide evidence of
microvessel abnormalities that may underpin SVD lesions in the brain.</p></abstract><kwd-group><kwd>OCTA</kwd><kwd>vessel density</kwd><kwd>capillary branching</kwd><kwd>cerebrovascular reactivity</kwd><kwd>perivascular spaces</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts2</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-0271678X221135658"><title>Introduction</title><p>Cerebral small vessel disease (SVD) is a major cause of stroke and dementia yet its
underlying mechanism remains unclear and treatments are limited. SVD pathophysiology
is mainly thought to occur at the level of brain perforating microvessels and
includes impaired vasodilation, subtle blood-brain barrier leakage and perivascular
tissue damage,<sup>
<xref rid="bibr1-0271678X221135658" ref-type="bibr">1</xref>
</sup> and vessel stiffening which could together impair glymphatic
drainage.<sup><xref rid="bibr2-0271678X221135658" ref-type="bibr">2</xref>,<xref rid="bibr3-0271678X221135658" ref-type="bibr">3</xref></sup>
Common structural brain imaging features of SVD include white matter
hyperintensities (WMH) and perivascular spaces (PVS).<sup>
<xref rid="bibr4-0271678X221135658" ref-type="bibr">4</xref>
</sup> Magnetic resonance imaging (MRI) methods like blood oxygen level dependent
(BOLD) cerebrovascular reactivity (CVR) imaging with hypercapnic stimulus<sup>
<xref rid="bibr5-0271678X221135658" ref-type="bibr">5</xref>
</sup> and diffusion tensor imaging (DTI)<sup>
<xref rid="bibr6-0271678X221135658" ref-type="bibr">6</xref>
</sup> can identify vascular dysfunction and white matter damage, respectively, in
brain tissue.</p><p>Blood vessels in the retina share many features with similarly sized vessels in the
brain, including their embryological origin and anatomic and physiological characteristics.<sup>
<xref rid="bibr7-0271678X221135658" ref-type="bibr">7</xref>
</sup> By examining the condition of the retina’s microvascular system that is
captured on non-invasive imaging, from the main arcades (∼40 μm in diameter)
observed on fundus photography, to the capillaries (down to 8 μm) seen with newer
technologies such as optical coherence tomography angiography (OCTA),<sup>
<xref rid="bibr8-0271678X221135658" ref-type="bibr">8</xref>
</sup> we might draw useful conclusions about the brain’s microvascular health. OCTA
might even be able to detect early microvascular changes before sequela are visible
with brain imaging modalities.</p><p>Previous investigations with fundus photography have shown that patients with small
vessel (lacunar) stroke have wider venules,<sup>
<xref rid="bibr9-0271678X221135658" ref-type="bibr">9</xref>
</sup> smaller arterioles<sup>
<xref rid="bibr10-0271678X221135658" ref-type="bibr">10</xref>
</sup> and decreased fractal dimension of the vessel branching pattern, suggesting a
sub-optimal microvascular network compared with other ischemic stroke subtypes.<sup>
<xref rid="bibr11-0271678X221135658" ref-type="bibr">11</xref>
</sup> Moreover, retinal microvascular abnormalities (such as focal arteriolar
narrowing and arteriovenous nicking) observed on fundus imaging are associated with
incident lacunar stroke during follow-up,<sup>
<xref rid="bibr12-0271678X221135658" ref-type="bibr">12</xref>
</sup> and retinopathy (such as microaneurysms, haemorrhages and exudates) is
associated with dementia<sup>
<xref rid="bibr13-0271678X221135658" ref-type="bibr">13</xref>
</sup> and stroke.<sup>
<xref rid="bibr14-0271678X221135658" ref-type="bibr">14</xref>
</sup></p><p>Markers of SVD in the brain have also been shown to associate with findings from
fundus imaging. These include an increase in PVS volume associated with decreasing
fractal dimension<sup>
<xref rid="bibr15-0271678X221135658" ref-type="bibr">15</xref>
</sup> and increased retinal vessel branching coefficients with periventricular WMH.<sup>
<xref rid="bibr16-0271678X221135658" ref-type="bibr">16</xref>
</sup></p><p>OCTA is a relatively recent advance in retinal imaging which visualizes retinal
capillaries, and is described as having ‘near histology level resolution’<sup>
<xref rid="bibr8-0271678X221135658" ref-type="bibr">8</xref>
</sup> (see Kashani et al.<sup>
<xref rid="bibr8-0271678X221135658" ref-type="bibr">8</xref>
</sup> for its application in eye disease). In neurological disease, a recent
systematic review<sup>
<xref rid="bibr17-0271678X221135658" ref-type="bibr">17</xref>
</sup> found changes on OCTA in the foveal avascular zone, perfusion density and
vessel density (VD) in patients with Alzheimer’s disease (AD) and pre-symptomatic AD
but sparse data precluded conclusion about OCTA findings in SVD and whether
decreased VD was associated with worse WMH. There was no information on other SVD
features such as PVS and few studies accounted for covariates. Therefore, whether
and how OCTA imaging features relate to brain imaging features in sporadic SVD
remains unclear.</p><p>Here, we investigated associations between retinal microvascular parameters measured
using OCTA and SVD markers from brain MRI including visible SVD lesions, blood flow,
cerebrovascular reactivity, and DTI measurements of white matter microstructural
integrity in patients with SVD who presented with a minor stroke.</p></sec><sec sec-type="Materials|methods" id="sec2-0271678X221135658"><title>Materials and methods</title><sec id="sec3-0271678X221135658"><title>Participants</title><p>We recruited adult patients with mild (i.e., expected to be non-disabling)
ischemic stroke (Modified Rankin Scale ≤2) from NHS Lothian clinical stroke
services into the Mild Stroke Study 3 (MSS-3; ISRCTN registry 12113543). We
excluded patients with contraindications to MRI, incapacity to consent or severe
cardiac failure or respiratory disease. Assessments included clinical, lifestyle
and cognitive assessments, blood tests and brain and retinal imaging at baseline
(up to 3 months after stroke), three months, six months and one-year. The
rationale for the study along with the protocol and design of this single
centre, observational, longitudinal cohort study and details of data collection
have been published.<sup>
<xref rid="bibr18-0271678X221135658" ref-type="bibr">18</xref>
</sup></p><p>Here we focus on the baseline visit in which retinal imaging and brain MRI were
conducted on the same day. The South East Scotland Research Ethics Committee
(18/SS/0044) approved the study and all participants gave written informed
consent. All procedures were conducted according to the Declaration of Helsinki
of 1975 (and as revised in 1983).</p></sec><sec id="sec4-0271678X221135658"><title>Vascular risk factors</title><p>Medical histories including cardiovascular risk factors such as smoking status,
previous stroke, hypertension, hypercholesterolemia, and diabetes mellitus and
currently prescribed medications were recorded.<sup>
<xref rid="bibr18-0271678X221135658" ref-type="bibr">18</xref>
</sup> All patients received guideline secondary stroke prevention
(antiplatelet, antihypertensive and lipid lowering agents). Resting blood
pressure readings were recorded.</p></sec><sec id="sec5-0271678X221135658"><title>MRI brain image acquisition</title><p>Full details of the brain imaging scanning protocol for MSS-3 have been published.<sup>
<xref rid="bibr18-0271678X221135658" ref-type="bibr">18</xref>
</sup> Briefly, participants underwent brain MRI at 3T (MAGNETOM Prisma, Siemens
Healthcare GmbH, Erlangen, Germany) with the following sequences: 3D T1-weighted
(1 mm<sup>3</sup> isotropic; TR 2500; TE 4.37), T2-weighted
(0.9 mm<sup>3</sup> isotropic; TR 3200; TE 408), fluid attenuated inversion
recovery-weighted (FLAIR) (1 mm<sup>3</sup> isotropic; TR 5000; TE 388; TI
1100), susceptibility-weighted (SWI) (0.6 × 0.6 × 3 mm; TR 28; TE 20), inversion
recovery spin gradient sequence (IR_SPGR) and multi-shell diffusion MRI. At the
same visit, we also measured BOLD response to 6% CO<sub>2</sub> as a
standardized measure of cerebrovascular reactivity (CVR) (see below), and total
blood through the internal carotid and vertebral arteries to calculate mean
arterial blood flow across the cardiac cycle and total cerebral blood flow (CBF).<sup>
<xref rid="bibr18-0271678X221135658" ref-type="bibr">18</xref>
</sup></p></sec><sec id="sec6-0271678X221135658"><title>Analysis of MRI data</title><p>
<list list-type="bullet" id="list1-0271678X221135658"><list-item><p>Visual rating of SVD</p></list-item></list>All MRI visual assessments of SVD were conducted with reference to STRIVE guidelines.<sup>
<xref rid="bibr4-0271678X221135658" ref-type="bibr">4</xref>
</sup> We used the Fazekas<sup>
<xref rid="bibr19-0271678X221135658" ref-type="bibr">19</xref>
</sup> scale to visually rate WMH and validated tools to grade PVS in the
centrum semiovale (CSO PVS) and basal ganglia (BG PVS).<sup><xref rid="bibr20-0271678X221135658" ref-type="bibr">20</xref>,<xref rid="bibr21-0271678X221135658" ref-type="bibr">21</xref></sup> Further
details are in Supplementary Material. <list list-type="bullet" id="list2-0271678X221135658"><list-item><p>Intracranial volume, brain tissue volumes and quantitative image
analysis of WMH and PVS</p></list-item></list></p><p>All image sequences were co-registered to the T2-weighted sequence and processed
with FLIRT,<sup>
<xref rid="bibr22-0271678X221135658" ref-type="bibr">22</xref>
</sup> FSL,<sup>
<xref rid="bibr23-0271678X221135658" ref-type="bibr">23</xref>
</sup> BET2<sup>
<xref rid="bibr24-0271678X221135658" ref-type="bibr">24</xref>
</sup> and in-house software as described in full in Supplementary Material.
<list list-type="bullet" id="list3-0271678X221135658"><list-item><p>Arterial blood flow to the brain</p></list-item></list></p><p>We manually segmented the internal carotid and vertebral arteries on the phase
contrast maximum magnitude image using FSLEyes (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLeyes" ext-link-type="uri">https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLeyes</ext-link>) and corrected
for background phase error.<sup><xref rid="bibr25-0271678X221135658" ref-type="bibr">25</xref>,<xref rid="bibr26-0271678X221135658" ref-type="bibr">26</xref></sup> Here, we compare mean
arterial blood flow across the cardiac cycle (ml/s) in relation to OCTA metrics.
<list list-type="bullet" id="list4-0271678X221135658"><list-item><p>Cerebrovascular reactivity of brain vessels</p></list-item></list></p><p>We assessed CVR using a block design gas challenge alternating between medical
air (2 minutes) and air with 6% carbon dioxide (CO<sub>2</sub>) (3 minutes)
using an established protocol.<sup><xref rid="bibr5-0271678X221135658" ref-type="bibr">5</xref>,<xref rid="bibr27-0271678X221135658" ref-type="bibr">27</xref><xref rid="bibr28-0271678X221135658" ref-type="bibr"/>–<xref rid="bibr29-0271678X221135658" ref-type="bibr">29</xref></sup> We calculated two metrics
using linear regression of the mean BOLD signal in NAWM against the end tidal
CO<sub>2</sub> with a variable delay and controlling for drift using
in-house MATLAB code as previously described.<sup>
<xref rid="bibr5-0271678X221135658" ref-type="bibr">5</xref>
</sup> CVR magnitude is the amplitude of the response (higher indicates a
stronger vasodilatory response) given in % BOLD signal change per mmHg change in
end tidal CO<sub>2</sub> (%/mmHg). CVR measurements analyzed here are derived
from NAWM masks. <list list-type="bullet" id="list5-0271678X221135658"><list-item><p>Diffusion imaging to assess white matter integrity</p></list-item></list></p><p>All WMH and NAWM diffusion measurements were computed in diffusion space as
described in full in Supplementary Material.</p></sec><sec id="sec7-0271678X221135658"><title>Retinal imaging</title><p>The retinal examination used spectral domain optical coherence tomography (OCT)
with eye tracking technology (SPECTRALIS OCT2, Heidelberg Engineering, Germany)
with both left and right eyes imaged.<sup>
<xref rid="bibr18-0271678X221135658" ref-type="bibr">18</xref>
</sup> We recorded self-declared eye disease (diabetic retinopathy, glaucoma,
and age-related macular degeneration) which we checked against our
ophthalmological graded assessments of the images. Queries were resolved by an
ophthalmologist (B.D.).</p></sec><sec id="sec8-0271678X221135658"><title>OCTA image acquisition</title><p>The macula was localized by a scanning laser ophthalmoscope infrared fundus
image. Next, a 10° × 10° structural OCT image was captured together with the
corresponding OCTA flow data, detected by variation in acquired signal and
representing the movement of red blood cells through vessels.<sup>
<xref rid="bibr8-0271678X221135658" ref-type="bibr">8</xref>
</sup> The scan pattern in MSS-3 consists of 512 B-Scans separated at 6 μm
intervals. The combined structural OCT and functional OCTA covers 3 mm × 3 mm of
the retina, centered at the fovea.</p></sec><sec id="sec9-0271678X221135658"><title>OCTA image processing</title><p>All image analysis was performed masked to patient characteristics and all other
data (i.e., retinal imaging masked to MRI and clinical data, and vice versa).
<italic toggle="yes">Enface</italic> transverse images of the superficial vascular
complex (SVC) were extracted – i.e., vessels bounded by the internal limiting
membrane to inner plexiform layer, being the vessels that supply blood to the
retinal nerve fiber layer and ganglion cells (<xref rid="fig1-0271678X221135658" ref-type="fig">Figure 1</xref>). These images were processed
using bespoke software written in MATLAB (MathWorks, Natik, MA, USA; version
2016a).</p><fig position="float" id="fig1-0271678X221135658" orientation="portrait"><label>Figure 1.</label><caption><p>(a) <italic toggle="yes">Enface</italic> optical coherence tomography angiography
(OCTA) transverse image of the superficial vascular complex with (b)
corresponding structural and OCTA flow image where yellow colouration
represents blood flow in vessels and segmentation (red dotted lines)
bounds the internal limiting membrane to inner plexiform layer.
Processed images: (c) adaptive threshold with Hessian filter and (d)
skeletonized image.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_0271678X221135658-fig1.jpg"/></fig></sec><sec id="sec10-0271678X221135658"><title>Vessel density and vessel branching complexity</title><p>VD was calculated from a binary map of the vessels and indicates the percentage
of vessel area (white pixels to black background) occupying the image.<sup>
<xref rid="bibr30-0271678X221135658" ref-type="bibr">30</xref>
</sup> To create the binary map a pre-processing step was performed using
Hessian-based Frangi filters to enhance vessel structures. Next, the filtered
image was thresholded using Otsu (‘global’) and local (‘adaptive’) thresholding
methods. The outputs from both methods were combined to generate the final
binary map that contained vessels where both threshold images agreed. Larger
values of VD reflect greater density.</p><p>Fractal analysis quantifies the complexity of the vessel branching pattern
visible in a retinal image in terms of fractal dimension, being a single value
that summarizes how complex or sparse the vascular pattern is.<sup><xref rid="bibr30-0271678X221135658" ref-type="bibr">30</xref>,<xref rid="bibr31-0271678X221135658" ref-type="bibr">31</xref></sup> We used a
multifractal/multispectral approach that models the vascular pattern in the
binary map as if composed of many fractals with different fractal dimensions
depending on the scale,<sup>
<xref rid="bibr32-0271678X221135658" ref-type="bibr">32</xref>
</sup> yielding a spectrum of fractal dimensions.<sup>
<xref rid="bibr33-0271678X221135658" ref-type="bibr">33</xref>
</sup> Values are unitless, with larger numbers reflecting greater
complexity.</p></sec><sec id="sec11-0271678X221135658"><title>Quality of OCTA images</title><p>Image quality can be affected by patient movement and media opacities such as
cataracts which adversely impact the measurement process. The manufacturer’s
OCTA quality index, Q, being the average signal strength measured in decibels
for all structural B-scans in the image volume, was recorded for each eye.
B-scans of Q &lt; 20 are rejected during acquisition, thus the averaged Q has a
lower bound of 20. Healthy eyes with no media opacities can achieve Q values of
around 40 or higher, thus Q tends to range from 20 to 40. Heidelberg Engineering
suggests good OCTA <italic toggle="yes">enface</italic> images are obtained with Q
&gt; = 28.</p><p>Q does not always correlate well with image quality as perceived by a human
rater. Important factors not captured in Q include focus and residual eye
motion. Thus, two trained raters (S.J.W. and J.F.Z.) visually graded the
interpretability of all OCTA images independently on an ordinal scale with 5
categories (1 = “Inadequate”, 2 = “Poor”, 3 = “Average”, 4 = “Good” and
5 = “Excellent”) (examples given in Supplementary Figure 1), and disagreements
were resolved by discussion. Agreement between raters was determined by
intraclass correlation coefficient (ICC)<sup>
<xref rid="bibr34-0271678X221135658" ref-type="bibr">34</xref>
</sup> with estimates calculated using the ‘irr’ package.<sup>
<xref rid="bibr35-0271678X221135658" ref-type="bibr">35</xref>
</sup> The final consensus in visual assessment was then compared to Q using
Spearman’s correlation.</p></sec><sec id="sec12-0271678X221135658"><title>OCTA image quality: inter-rater visual agreement and correlation with signal
strength</title><p>Rater agreement in OCTA image quality visual assessment was ICC 0.71 [95%CI 0.53
to 0.82] and ICC 0.69 [0.41 to 0.83] for right and left eyes respectively.
Spearman’s correlation between the visual assessment consensus and the
instrument manufacturer’s signal strength Q index was <italic toggle="yes">r</italic> = 0.62
and <italic toggle="yes">r</italic> = 0.56 for right and left eyes, respectively. We account
for image quality in the primary analyses by adding it as a covariate in the
adjusted models.</p></sec><sec id="sec13-0271678X221135658"><title>Statistical analysis</title><p>Data were checked for normality by visual inspection of the distributions and by
Kolmogorov-Smirnov test. We log transformed WMH volumes. Missing data were
recorded (<xref rid="table1-0271678X221135658" ref-type="table">Table 1</xref>).
All analyses were per patient, and although we analyze both right and left eyes,
we do so as separate tasks, and show results from both eyes for transparency.
Eye asymmetry could be important.<sup>
<xref rid="bibr36-0271678X221135658" ref-type="bibr">36</xref>
</sup></p><table-wrap position="float" id="table1-0271678X221135658" orientation="portrait"><label>Table 1.</label><caption><p>Mild Stroke Study 3 demographics, OCTA data, co-morbid eye disease,
vascular risks, and comprehensive brain imaging data at baseline.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_0271678X221135658-table1.jpg"/><table frame="hsides" rules="groups"><tbody valign="top"><tr><td rowspan="1" colspan="1">Mean age (years)</td><td rowspan="1" colspan="1">68.1 (SD 9.9)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Male/Female</td><td rowspan="1" colspan="1">80/43</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">OCTA</td><td rowspan="1" colspan="1"><italic toggle="yes">Right eye (N</italic> = <italic toggle="yes">104)</italic></td><td rowspan="1" colspan="1"><italic toggle="yes">Left eye (N</italic> = <italic toggle="yes">105)</italic></td></tr><tr><td rowspan="1" colspan="1">Vessel density (%)</td><td rowspan="1" colspan="1">32.1 (SD 5.62)</td><td rowspan="1" colspan="1">32.1 (SD 5.24)</td></tr><tr><td rowspan="1" colspan="1">Fractal complexity (unitless)</td><td rowspan="1" colspan="1">1.81 (SD 0.03)</td><td rowspan="1" colspan="1">1.82 (0.03)</td></tr><tr><td rowspan="1" colspan="1">OCTA image quality</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Signal strength ‘Q’ (decibels)</td><td rowspan="1" colspan="1">37.3 (SD 2.92)</td><td rowspan="1" colspan="1">37.7 (SD 2.90)</td></tr><tr><td rowspan="1" colspan="1">  1 Inadequate (N)</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">9</td></tr><tr><td rowspan="1" colspan="1">  2 Poor (N)</td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">31</td></tr><tr><td rowspan="1" colspan="1">  3 Average (N)</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">47</td></tr><tr><td rowspan="1" colspan="1">  4 Good (N)</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">10</td></tr><tr><td rowspan="1" colspan="1">  5 Excellent (N)</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">8</td></tr><tr><td rowspan="1" colspan="1">Co-morbid eye disease</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = <italic toggle="yes">117</italic></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Diabetic retinopathy</td><td rowspan="1" colspan="1">6/117 (5.13%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Glaucoma</td><td rowspan="1" colspan="1">3/117 (2.56%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> AMD</td><td rowspan="1" colspan="1">5/117 (4.27%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Any of the above</td><td rowspan="1" colspan="1">14/117 (11.96%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Vascular risk factors</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = <italic toggle="yes">123</italic></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Diabetes</td><td rowspan="1" colspan="1">27/123 (21.9%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Hypertension</td><td rowspan="1" colspan="1">87/123 (70.7%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Hypercholesterolemia</td><td rowspan="1" colspan="1">92/123 (74.7%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Smoker: current</td><td rowspan="1" colspan="1">14/123 (11.4%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Smoker: never <italic toggle="yes">v.</italic> ever</td><td rowspan="1" colspan="1">56/123 (45.5%) <italic toggle="yes">v.</italic> 67/123 (54.4%)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Mean SBP (mmHg)</td><td rowspan="1" colspan="1">149.0 ± 19.67</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">White matter lesions</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = <italic toggle="yes">122</italic></td><td rowspan="1" colspan="1">
<italic toggle="yes">% of ICV</italic>
</td></tr><tr><td rowspan="1" colspan="1"> ICV volume (ml)</td><td rowspan="1" colspan="1">1,612.0 (SD 160.4)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> WMH volume, median (ml)</td><td rowspan="1" colspan="1">8.17 (3.47–18.60)</td><td rowspan="1" colspan="1">0.50</td></tr><tr><td rowspan="1" colspan="1"> Fazekas periventricular (0:3)</td><td rowspan="1" colspan="1">1.5 (1–2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Fazekas deep (0:3)</td><td rowspan="1" colspan="1">1 (1–2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Fazekas total (0:6)</td><td rowspan="1" colspan="1">3 (2–3)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PVS: computational</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = <italic toggle="yes">115</italic></td><td rowspan="1" colspan="1">
<italic toggle="yes">% of CSO or BG</italic>
<sup>a</sup>
</td></tr><tr><td rowspan="1" colspan="1"> PVS volume in CSO (ml)</td><td rowspan="1" colspan="1">11.5 (6.9–17.5)</td><td rowspan="1" colspan="1">3.6 (2.2–5.8)</td></tr><tr><td rowspan="1" colspan="1"> PVS volume in BG (ml)</td><td rowspan="1" colspan="1">2.9 (2.1–3.8)</td><td rowspan="1" colspan="1">4.9 (3.7–6.0)</td></tr><tr><td rowspan="1" colspan="1"> PVS count in CSO</td><td rowspan="1" colspan="1">890 (302)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> PVS count in BG</td><td rowspan="1" colspan="1">170 (41)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PVS: visual ratings</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = <italic toggle="yes">122</italic></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> CSO PVS</td><td rowspan="1" colspan="1">3 (2–3)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> BG PVS</td><td rowspan="1" colspan="1">2 (1–2)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Blood flow to the brain</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = <italic toggle="yes">100</italic></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Arterial mean (ml/s)</td><td rowspan="1" colspan="1">9.44 (SD 1.94)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Cerebrovascular reactivity</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = <italic toggle="yes">114</italic></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> CVR magnitude (%/mmHg)</td><td rowspan="1" colspan="1">0.043 (SD 0.020)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> CVR delay (s)</td><td rowspan="1" colspan="1">30.89 (SD 21.0)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">White matter integrity</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = <italic toggle="yes">117</italic></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> FA in NAWM (unitless)</td><td rowspan="1" colspan="1">0.42 (SD 0.02)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> FA in WMH (unitless)</td><td rowspan="1" colspan="1">0.27 (SD 0.04)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> MD in NAWM (10<sup>–3</sup> mm<sup>2</sup>/s)</td><td rowspan="1" colspan="1">0.76 (SD 0.02)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> MD in WMH (10<sup>–3</sup> mm<sup>2</sup>/s)</td><td rowspan="1" colspan="1">1.09 (SD 0.07)</td><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-0271678X221135658"><p>AMD: age-related macular degeneration. BG: basal ganglia. CSO:
centrum semiovale. CVR: cerebrovascular reactivity. FA: fractional
anisotropy. ICV: inter cranial volume. MD: mean diffusivity. NAWM:
normal appearing white matter. PVS: perivascular spaces. SBP:
systolic blood pressure. WMH: white matter hyperintensity.</p></fn><fn id="table-fn2-0271678X221135658"><p><sup>a</sup>PVS volume as a percentage of the region of interest,
either CSO or BG. ICV volume and PVS counts as mean (SD), other
volumes have non-normal distributions and so presented as medians
(interquartile range, Q1–Q3).</p></fn></table-wrap-foot></table-wrap><p>WMH volumes were corrected for ICV volume, and PVS volumes corrected for the
relevant region of interest volume, either centrum semiovale or basal ganglia.
PVS counts are given as counts without correction for a region of interest.</p><p>We used linear regression to investigate univariate associations between VD and
branching pattern fractal complexity as outcomes of interest with various
predictor variables: age and sex, vascular risks (smoking, blood pressure
measures, hypertension, diabetes, high cholesterol) and various brain MRI
measurements. Next, multiple general linear models estimated the relationship
between OCTA variables and brain imaging variables, controlling for key
co-variates: comorbid eye disease, age, diabetes, blood pressure and OCTA image
quality. Model estimates for the continuous predictors are presented as
standardized betas (β). All statistical analyses were conducted in R Studio
using R version 3.6.1.</p></sec></sec><sec sec-type="results" id="sec14-0271678X221135658"><title>Results</title><p>We analyzed data from the baseline visit obtained on average 53 days (range 6–95
days) after index stroke symptoms in 123 consecutive participants recruited to MSS-3
between August 2018 and August 2020. Mean age across the cohort was 68.1 ± SD 9.9
years (range 40–86 years).</p><p>There were 80/123 (65%) men, 14/123 (11.4%) smokers, 27/123 (21.9%) had diabetes and
87/123 (70.7%) were hypertensive. Median WMH volume was 8.17 ml (interquartile
range: 3.47–18.60). Patient-level missing data were due to technical and
organizational issues with retinal image acquisition (N = 8) leaving N = 115
participants with retinal examinations (mean age of these 115 was 68.2 ± SD 10.0
years). Eleven right and 10 left eye OCTAs were not performed or were unsuccessful
due to severe eye disease, leaving 104 right and 105 left eyes for the current
analyses.</p><p>Patient demographics and baseline retinal and brain imaging measurements are given in
<xref rid="table1-0271678X221135658" ref-type="table">Table 1</xref>. One
participant did not have a baseline brain scan due to MRI claustrophobia but is
retained in the analysis to contribute to the summarized vascular risks and eye data
in <xref rid="table1-0271678X221135658" ref-type="table">Table 1</xref>. VD and
branching complexity (i.e., multispectral fractal dimension) were correlated: right
eye <italic toggle="yes">r</italic> = 0.93 and left eye <italic toggle="yes">r</italic> = 0.90.</p><sec id="sec15-0271678X221135658"><title>OCTA retinal vessel density</title><p>We analyze and report right (R) and left (L) eyes separately. On univariate
analyses, lower VD related to older age, hypertension, diabetes, and comorbid
eye disease, as well as more WMH, more CSO and BG PVS, and MD both in NAWM and
in WMH (Supplementary Figure S2). As expected, higher VD related to better image
quality, higher CVR magnitude and higher FA in NAWM (Supplementary Figure
S2).</p><p>After adjusting for age, eye disease, diabetes, blood pressure and image quality,
lower VD remained associated with higher MD (standardized β; R −0.16 [95%CI
−0.32 to −0.01]) and lower CVR (L 0.17 [0.03 to 0.31] and R 0.19 [0.02 to 0.36])
in NAWM (<xref rid="fig2-0271678X221135658" ref-type="fig">Figure 2</xref>). We
did not find any association between VD and arterial blood flow.</p><fig position="float" id="fig2-0271678X221135658" orientation="portrait"><label>Figure 2.</label><caption><p>Fully adjusted models. OCTA vessel density (panels a and b) and vessel
branching complexity (panels c and d) in relation to brain imaging
variables characterizing SVD, after adjustment for age, eye disease,
diabetes, systolic blood pressure and OCTA image quality. CSO PVS:
centrum semiovale perivascular spaces; CVR: cerebrovascular reactivity;
FA: fractional anisotropy; MD: mean diffusivity; OCTA: optical coherence
tomography angiography; SVD: small vessel disease; WMH: white matter
hyperintensities.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_0271678X221135658-fig2.jpg"/></fig></sec><sec id="sec16-0271678X221135658"><title>OCTA retinal vessel branching complexity (fractal dimension)</title><p>On univariate analyses, less complex branching related to older age, diabetes,
comorbid eye disease, greater WMH burden, more CSO PVS and BG PVS and higher MD
in NAWM (Supplementary Figure S3). More complex branching related to better
image quality and higher FA in NAWM (Supplementary Figure S3). After adjusting
for covariates, sparser branching associated with higher MD (R −0.24 [−0.08 to
−0.40]) and lower FA (L 0.17 [0.01 to 0.33]), and lower CVR (R 0.20 [0.02 to
0.38]) in NAWM (<xref rid="fig2-0271678X221135658" ref-type="fig">Figure
2</xref>). We did not find any association between branching complexity and
arterial blood flow.</p></sec></sec><sec sec-type="discussion" id="sec17-0271678X221135658"><title>Discussion</title><p>This study demonstrates that lower retinal VD on OCTA is associated with higher MD
and lower CVR magnitude in NAWM, consistent with a reduction in small vessel density
in the brain underpinning the observed impairments in vascular function and
sub-visible white matter structure seen with increasing SVD lesion burden. We also
observed lower branching complexity (fractal dimension) with lower CVR magnitude,
and with sub-visible white matter damage suggested by higher MD and lower FA in
NAWM.</p><p>CVR estimates the adequacy of the change in blood flow in response to a vasoactive
stimulus, and is impaired in SVD particularly in affected tissues.<sup>
<xref rid="bibr29-0271678X221135658" ref-type="bibr">29</xref>
</sup> CVR magnitude in white matter is lower in patients with more severe SVD features,<sup>
<xref rid="bibr28-0271678X221135658" ref-type="bibr">28</xref>
</sup> and CVR delay is longer in SVD patients than healthy controls.<sup><xref rid="bibr5-0271678X221135658" ref-type="bibr">5</xref>,<xref rid="bibr37-0271678X221135658" ref-type="bibr">37</xref>,<xref rid="bibr38-0271678X221135658" ref-type="bibr">38</xref></sup> Here, we found that lower
retinal VD on OCTA was associated with lower CVR magnitude in NAWM after correcting
for a range of key covariates, also validating the results of a much smaller
(N = 11) study of older subjects.<sup>
<xref rid="bibr39-0271678X221135658" ref-type="bibr">39</xref>
</sup> Lower branching complexity related to lower CVR and higher MD in NAWM.</p><p>Increased MD occurs in WMH and also in NAWM as the severity of SVD lesions increase
and indicates sub-visible alterations in white matter integrity.<sup>
<xref rid="bibr40-0271678X221135658" ref-type="bibr">40</xref>
</sup> No prior studies investigated the relationship between OCTA parameters and
DTI measures of white matter structural integrity in SVD. Here, we found that lower
retinal VD on OCTA was associated with increased MD in NAWM, consistent with vessel
density decreasing in NAWM as the SVD burden worsens. Here, reduced branching
complexity also related to more sub-visible white matter damage (higher MD and lower
FA in NAWM) in keeping with increased interstitial fluid content and mobility,
demyelination, and axonal loss. It will be important to assess whether early retinal
vascular changes can predict WMH progression and white matter damage in the long
term.</p><p>PVS in the brain are a marker of vascular dysfunction, amongst several associations,
and occur early in development of SVD.<sup>
<xref rid="bibr41-0271678X221135658" ref-type="bibr">41</xref>
</sup> We have previously demonstrated a link between increasing PVS volumes and
decreasing fractal dimension of larger retinal arterioles on fundus photography,<sup>
<xref rid="bibr15-0271678X221135658" ref-type="bibr">15</xref>
</sup> as did a previous study of PVS in the CSO.<sup>
<xref rid="bibr42-0271678X221135658" ref-type="bibr">42</xref>
</sup> Here, there were strong univariate associations between both lower VD and
less complex branching and more PVS (computational volumes and counts but not visual
ratings), but none survived adjustment for covariates. The typical vessel
arborization pattern of the retina is thought to be in accordance with Murray’s Law
of Minimal Work, which strives for less energy dissipation and maximum efficiency of
energy use when transporting blood.<sup>
<xref rid="bibr43-0271678X221135658" ref-type="bibr">43</xref>
</sup> Reduction from the optimized vessel branching to sparser patterns may link to
SVD lesions through impaired small vessel function (as reflected in impaired CVR)
and less efficient energy management.</p><p>WMH are a common feature of cerebral SVD on brain MRI. Previous retinal OCTA studies
used Fazekas score to represent WMH severity, with inconsistent findings.<sup><xref rid="bibr17-0271678X221135658" ref-type="bibr">17</xref>,<xref rid="bibr39-0271678X221135658" ref-type="bibr">39</xref>,<xref rid="bibr44-0271678X221135658" ref-type="bibr">44</xref>,<xref rid="bibr45-0271678X221135658" ref-type="bibr">45</xref></sup> In a wide
range of study populations including AD, mild cognitive impairment (MCI), SVD or
cognitively normal adults, some studies<sup><xref rid="bibr17-0271678X221135658" ref-type="bibr">17</xref>,<xref rid="bibr39-0271678X221135658" ref-type="bibr">39</xref>,<xref rid="bibr44-0271678X221135658" ref-type="bibr">44</xref></sup> observed that decreased VD on
OCTA was associated with increased Fazekas score, while others<sup><xref rid="bibr17-0271678X221135658" ref-type="bibr">17</xref>,<xref rid="bibr45-0271678X221135658" ref-type="bibr">45</xref></sup> showed no
significant association which might partly be due to small sample size.<sup>
<xref rid="bibr17-0271678X221135658" ref-type="bibr">17</xref>
</sup> Here, worse WMH (computationally and by visual score) strongly related to
reduced VD and reduced branching on univariate analyses (Supplementary Figure S2)
but effects were lost in fully adjusted analyses.</p><p>In our study, we did not find an association between OCTA measures and resting
arterial blood flow, possibly suggesting retinal/central perfusion stability. In a
small study (35 eyes from 18 patients) of pre- and post-operative major
non-neurological surgery requiring planned intensive therapy unit (ITU) admission,<sup>
<xref rid="bibr46-0271678X221135658" ref-type="bibr">46</xref>
</sup> retinal blood flow was stable and the authors conclude that the stability of
retinal blood flow measures suggests the potential for OCTA to provide clinically
useful measures in ITU patients. OCTA could be used as a potential biomarker of
central perfusion in SVD but more data is needed. In a recent updated meta-analysis,<sup>
<xref rid="bibr47-0271678X221135658" ref-type="bibr">47</xref>
</sup> WMH were found to associate with reduced cerebral blood flow
cross-sectionally but when studies of patients with dementia or that failed to
account for vascular risk factors were excluded, the relationship disappeared.
Longitudinal associations between blood flow and SVD burden are mixed and remain unclear.<sup>
<xref rid="bibr47-0271678X221135658" ref-type="bibr">47</xref>
</sup></p><p>The strengths of this study are the relatively large sample of patients with a
confirmed stroke, analyses of both eyes per participant, a comprehensive brain
imaging protocol that generated key brain imaging metrics describing SVD, and
adjustment for vascular risk factors and OCTA image quality. We also acknowledge
weaknesses. The cross-sectional design precludes inferences on the temporal link
between impaired retinal microvasculature and SVD progression but MSS-3 is gathering
the data to address retinal and brain changes in SVD. We did not assess retinal
vessels from the deep vascular layers. There are no data in our study representing a
non-stroke control group, rather, we are interested in within-group associations
between the eye and brain to help deepen our understanding of small vessel
dysfunction.</p><p>In conclusion, our study showed that impaired retinal capillary-level changes
identified using OCTA were associated with structural SVD markers and impaired
cerebral vasoreactivity. OCTA measures hold promise as non-invasive biomarkers of
cerebral SVD, being relatively easy to tolerate and economical. Longitudinal studies
are warranted to assess the predictive power of OCTA measurements for SVD
progression and monitor treatment responses.</p></sec><sec sec-type="supplementary-material" specific-use="figshare"><title>Supplemental Material</title><supplementary-material id="suppl1-0271678X221135658" position="float" content-type="local-data" orientation="portrait"><caption><title>sj-pdf-1-jcb-10.1177_0271678X221135658 - Supplemental material for
Retinal capillary microvessel morphology changes are associated with
vascular damage and dysfunction in cerebral small vessel disease</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sj-pdf-1-jcb-10.1177_0271678X221135658.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media><p>Supplemental material, sj-pdf-1-jcb-10.1177_0271678X221135658 for Retinal
capillary microvessel morphology changes are associated with vascular damage and
dysfunction in cerebral small vessel disease by Stewart J Wiseman, Jun-Fang
Zhang, Calum Gray, Charlene Hamid, Maria del C Valdés Hernández, Lucia
Ballerini, Michael J Thrippleton, Cameron Manning, Michael Stringer, Emilie
Sleight, Susana Muñoz Maniega, Alasdair Morgan, Yajun Cheng, Carmen Arteaga,
Dany Jaime Garcia, Una Clancy, Fergus N Doubal, Baljean Dhillon, Tom
MacGillivray, Yun-Cheng Wu and Joanna M Wardlaw in Journal of Cerebral Blood
Flow &amp; Metabolism</p></supplementary-material></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: This work is supported
by: the UK Dementia Research Institute which receives its funding from DRI Ltd,
funded by the UK MRC, Alzheimer’s Society and Alzheimer’s Research UK; the
Fondation Leducq Network for the Study of Perivascular Spaces in Small Vessel
Disease (16 CVD 05); Stroke Association ‘Small Vessel Disease-Spotlight on
Symptoms (SVD-SOS)’(SAPG 19\100068; British Heart Foundation Edinburgh Centre
for Research Excellence (RE/18/5/34216); The Row Fogo Charitable Trust Centre
for Research into Aging and the Brain; Stroke Association Garfield Weston
Foundation Senior Clinical Lectureship (F.N.D.) (TSALECT 2015/04); NHS Research
Scotland (F.N.D.); Stroke Association Post-Doctoral Fellowship (S.J.W.) (SAPDF
18/100026); NHS Lothian Research and Development Office (MJT); European Union
Horizon 2020, PHC-03–15, project No666881, ‘SVDs@Target’ (MS); Chief Scientist
Office of Scotland Clinical Academic Fellowship (UC) (CAF/18/08); Stroke
Association Princess Margaret Research Development Fellowship (UC) (2018);
Medical Research Scotland studentship (AM) (PhD-1165–2017); MRC Doctoral
Training Programme in Precision Medicine (CM) (MR/R01566X/1); Siemens Healthcare
(AM and CM); Science and Technology Innovation 2030-“Brain Science and
Brain-Like Intelligence Technology” Major Project (The China Brain Project) (No.
2021ZD0201905), Clinical Research Innovation Plan of Shanghai General Hospital
(CTCCR-2018B03) and the National Natural Science Foundation of China (81971185,
82171243). The research MRI scanner is supported by the Scottish Funding Council
through the Scottish Imaging Network, A Platform for Scientific Excellence
(SINAPSE) Collaboration; the Wellcome Trust (104916/Z/14/Z), Dunhill Trust
(R380R/1114), Edinburgh and Lothians Health Foundation (2012/17), Muir Maxwell
Research Fund and the University of Edinburgh.</p></fn><fn fn-type="COI-statement"><p>The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p></fn><fn fn-type="other"><p><bold>Authors’ contributions:</bold>
<italic toggle="yes">Conceptualization and Design</italic>: S.J.W., J-F.Z., T.MacG., Y-C.W.,
J.M.W.; <italic toggle="yes">Image processing, Investigations and Analysis</italic>: S.J.W.,
J-F.Z., C.G., C.H., M.V.H., L.B., M.J.T., C.M., M.S., E.S., S.M.M., A.M., Y.C.,
C.A., D.J.G., U.C.; <italic toggle="yes">Supervision</italic>: M.V.H., M.J.T., M.S., F.N.D.,
B.D., T.MacG., Y-C.W., J.M.W.; <italic toggle="yes">Writing</italic>: S.J.W., J-F.Z., M.S.,
E.S., S.M.M., T.MacG., Y-C.W., J.M.W; <italic toggle="yes">Review and Editing</italic>:
S.J.W., J-F.Z., C.G., M.V.H., M.J.T., F.N.D., B.D., T.MacG., Y-C.W., J.M.W. All
authors approved the final manuscript.</p></fn></fn-group><fn-group><fn fn-type="other"><p><bold>Supplemental material:</bold> Supplemental material for this article is available online.</p></fn></fn-group><sec id="sec18-0271678X221135658"><title>Open access publishing statement</title><p>This research was funded in whole, or in part, by the Wellcome Trust [Grant number
104916/Z/14/Z]. For the purpose of open access, the author has applied a CC BY
public copyright license to any Author Accepted Manuscript version arising from this
submission.</p></sec><sec><title>ORCID iDs</title><p>Stewart J Wiseman <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0001-6739-5797" ext-link-type="uri">https://orcid.org/0000-0001-6739-5797</ext-link></p><p>Calum Gray <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-2816-4707" ext-link-type="uri">https://orcid.org/0000-0002-2816-4707</ext-link></p><p>Michael Stringer <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-3811-4439" ext-link-type="uri">https://orcid.org/0000-0002-3811-4439</ext-link></p><p>Carmen Arteaga <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0003-2424-7123" ext-link-type="uri">https://orcid.org/0000-0003-2424-7123</ext-link></p><p>Joanna M Wardlaw <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-9812-6642" ext-link-type="uri">https://orcid.org/0000-0002-9812-6642</ext-link></p></sec><ref-list content-type="numbered"><title>References</title><ref id="bibr1-0271678X221135658"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davalos</surname><given-names>D</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>JK</given-names></name><name name-style="western"><surname>Merlini</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Fibrinogen-induced
perivascular microglial clustering is required for the development of axonal
damage in neuroinflammation</article-title>. <source>Nat Commun</source><year>2012</year>; <volume>3</volume>: <fpage>1227</fpage>.<pub-id pub-id-type="pmid">23187627</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms2230</pub-id><pub-id pub-id-type="pmcid">PMC3514498</pub-id></mixed-citation></ref><ref id="bibr2-0271678X221135658"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kida</surname><given-names>S.</given-names></name></person-group><article-title>Progress in diagnosis of and therapy for idiopathic
normal-pressure hydrocephalus – lymphatic drainage of CSF and ISF from the
brain: recent concept and hypothesis</article-title>. <source>Rinsho
Shinkeigaku</source><year>2014</year>; <volume>54</volume>:
<fpage>1187</fpage>–<lpage>1189</lpage>.<pub-id pub-id-type="pmid">25672741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5692/clinicalneurol.54.1187</pub-id></mixed-citation></ref><ref id="bibr3-0271678X221135658"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>XB</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XX</given-names></name><name name-style="western"><surname>Xia</surname><given-names>DH</given-names></name></person-group>, <etal>et al</etal>. <article-title>Impaired meningeal lymphatic
drainage in patients with idiopathic Parkinson’s disease</article-title>.
<source>Nat Med</source><year>2021</year>; <volume>27</volume>:
<fpage>411</fpage>–<lpage>418</lpage>.<pub-id pub-id-type="pmid">33462448</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-020-01198-1</pub-id></mixed-citation></ref><ref id="bibr4-0271678X221135658"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wardlaw</surname><given-names>JM</given-names></name><name name-style="western"><surname>Smith</surname><given-names>EE</given-names></name><name name-style="western"><surname>Biessels</surname><given-names>GJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Neuroimaging standards for
research into small vessel disease and its contribution to ageing and
neurodegeneration</article-title>. <source>Lancet Neurol</source><year>2013</year>; <volume>12</volume>:
<fpage>822</fpage>–<lpage>838</lpage>.<pub-id pub-id-type="pmid">23867200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(13)70124-8</pub-id><pub-id pub-id-type="pmcid">PMC3714437</pub-id></mixed-citation></ref><ref id="bibr5-0271678X221135658"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thrippleton</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Blair</surname><given-names>G</given-names></name></person-group>, <etal>et al</etal>. <article-title>Cerebrovascular reactivity
measurement in cerebral small vessel disease: rationale and reproducibility
of a protocol for MRI acquisition and image processing</article-title>.
<source>Int J Stroke</source><year>2018</year>; <volume>13</volume>:
<fpage>195</fpage>–<lpage>206</lpage>.<pub-id pub-id-type="pmid">28933655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1747493017730740</pub-id></mixed-citation></ref><ref id="bibr6-0271678X221135658"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasi</surname><given-names>M</given-names></name><name name-style="western"><surname>van Uden</surname><given-names>IWM</given-names></name><name name-style="western"><surname>Tuladhar</surname><given-names>AM</given-names></name></person-group>, <etal>et al</etal>. <article-title>White matter microstructural
damage on diffusion tensor imaging in cerebral small vessel disease:
clinical consequences</article-title>. <source>Stroke</source><year>2016</year>; <volume>47</volume>:
<fpage>1679</fpage>–<lpage>1684</lpage>.<pub-id pub-id-type="pmid">27103015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.115.012065</pub-id></mixed-citation></ref><ref id="bibr7-0271678X221135658"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patton</surname><given-names>N</given-names></name><name name-style="western"><surname>Aslam</surname><given-names>T</given-names></name><name name-style="western"><surname>MacGillivray</surname><given-names>T</given-names></name></person-group>, <etal>et al</etal>. <article-title>Retinal vascular image
analysis as a potential screening tool for cerebrovascular disease: a
rationale based on homology between cerebral and retinal
microvasculatures</article-title>. <source>J Anat</source><year>2005</year>; <volume>206</volume>:
<fpage>319</fpage>–<lpage>348</lpage>.<pub-id pub-id-type="pmid">15817102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1469-7580.2005.00395.x</pub-id><pub-id pub-id-type="pmcid">PMC1571489</pub-id></mixed-citation></ref><ref id="bibr8-0271678X221135658"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kashani</surname><given-names>AH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C-L</given-names></name><name name-style="western"><surname>Gahm</surname><given-names>JK</given-names></name></person-group>, <etal>et al</etal>. <article-title>Optical coherence tomography
angiography: a comprehensive review of current methods and clinical
applications</article-title>. <source>Prog Retin Eye Res</source><year>2017</year>; <volume>60</volume>:
<fpage>66</fpage>–<lpage>100</lpage>.<pub-id pub-id-type="pmid">28760677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.preteyeres.2017.07.002</pub-id><pub-id pub-id-type="pmcid">PMC5600872</pub-id></mixed-citation></ref><ref id="bibr9-0271678X221135658"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doubal</surname><given-names>FN</given-names></name><name name-style="western"><surname>MacGillivray</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Hokke</surname><given-names>PE</given-names></name></person-group>, <etal>et al</etal>. <article-title>Differences in retinal
vessels support a distinct vasculopathy causing lacunar
stroke</article-title>. <source>Neurology</source><year>2009</year>; <volume>72</volume>:
<fpage>1773</fpage>–<lpage>1778</lpage>.<pub-id pub-id-type="pmid">19451533</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0b013e3181a60a71</pub-id><pub-id pub-id-type="pmcid">PMC2827311</pub-id></mixed-citation></ref><ref id="bibr10-0271678X221135658"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindley</surname><given-names>RI</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M-C</given-names></name></person-group>, <etal>et al</etal>. <article-title>Retinal microvasculature in
acute lacunar stroke: a cross-sectional study</article-title>.
<source>Lancet Neurol</source><year>2009</year>; <volume>8</volume>:
<fpage>628</fpage>–<lpage>634</lpage>.<pub-id pub-id-type="pmid">19481977</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(09)70131-0</pub-id></mixed-citation></ref><ref id="bibr11-0271678X221135658"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doubal</surname><given-names>FN</given-names></name><name name-style="western"><surname>MacGillivray</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Patton</surname><given-names>N</given-names></name></person-group>, <etal>et al</etal>. <article-title>Fractal analysis of retinal
vessels suggests that a distinct vasculopathy causes lacunar
stroke</article-title>. <source>Neurology</source><year>2010</year>; <volume>74</volume>:
<fpage>1102</fpage>–<lpage>1107</lpage>.<pub-id pub-id-type="pmid">20368631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0b013e3181d7d8b4</pub-id><pub-id pub-id-type="pmcid">PMC2865776</pub-id></mixed-citation></ref><ref id="bibr12-0271678X221135658"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yatsuya</surname><given-names>H</given-names></name><name name-style="western"><surname>Folsom</surname><given-names>AR</given-names></name><name name-style="western"><surname>Wong</surname><given-names>TY</given-names></name></person-group>, <etal>et al</etal>. <article-title>Retinal microvascular
abnormalities and risk of lacunar stroke: atherosclerosis risk in
communities study</article-title>. <source>Stroke</source><year>2010</year>; <volume>41</volume>:
<fpage>1349</fpage>–<lpage>1355</lpage>.<pub-id pub-id-type="pmid">20522816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.110.580837</pub-id><pub-id pub-id-type="pmcid">PMC2894269</pub-id></mixed-citation></ref><ref id="bibr13-0271678X221135658"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGrory</surname><given-names>S</given-names></name><name name-style="western"><surname>Cameron</surname><given-names>JR</given-names></name><name name-style="western"><surname>Pellegrini</surname><given-names>E</given-names></name></person-group>, <etal>et al</etal>. <article-title>The application of retinal
fundus camera imaging in dementia: a systematic review.</article-title><source>Alzheimers Dement (Amst)</source><year>2017</year>; <volume>6</volume>:
<fpage>91</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">28229127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dadm.2016.11.001</pub-id><pub-id pub-id-type="pmcid">PMC5312461</pub-id></mixed-citation></ref><ref id="bibr14-0271678X221135658"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doubal</surname><given-names>FN</given-names></name><name name-style="western"><surname>Hokke</surname><given-names>PE</given-names></name><name name-style="western"><surname>Wardlaw</surname><given-names>JM.</given-names></name></person-group><article-title>Retinal microvascular abnormalities and stroke: a systematic
review</article-title>. <source>J Neurol Neurosurg Psychiatry</source><year>2009</year>; <volume>80</volume>:
<fpage>158</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">18931002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.2008.153460</pub-id></mixed-citation></ref><ref id="bibr15-0271678X221135658"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballerini</surname><given-names>L</given-names></name><name name-style="western"><surname>McGrory</surname><given-names>S</given-names></name><name name-style="western"><surname>Valdes Hernandez</surname><given-names>MDC</given-names></name></person-group>, <etal>et al</etal>. <article-title>Quantitative measurements of
enlarged perivascular spaces in the brain are associated with retinal
microvascular parameters in older community-dwelling
subjects</article-title>. <source>Cereb Circ Cog Behav</source><year>2020</year>; <volume>1</volume>:
<fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cccb.2020.100002</pub-id><pub-id pub-id-type="pmcid">PMC7792660</pub-id><pub-id pub-id-type="pmid">33458712</pub-id></mixed-citation></ref><ref id="bibr16-0271678X221135658"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doubal</surname><given-names>FN</given-names></name><name name-style="western"><surname>De Haan</surname><given-names>R</given-names></name><name name-style="western"><surname>MacGillivray</surname><given-names>TJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Retinal arteriolar geometry
is associated with cerebral white matter hyperintensities on magnetic
resonance imaging</article-title>. <source>Int J Stroke</source><year>2010</year>; <volume>5</volume>:
<fpage>434</fpage>–<lpage>439</lpage>.<pub-id pub-id-type="pmid">21050397</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1747-4949.2010.00483.x</pub-id><pub-id pub-id-type="pmcid">PMC3489044</pub-id></mixed-citation></ref><ref id="bibr17-0271678X221135658"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>JF</given-names></name><name name-style="western"><surname>Wiseman</surname><given-names>S</given-names></name><name name-style="western"><surname>Valdés Hernández</surname><given-names>MC</given-names></name></person-group>, <etal>et al</etal>. <article-title>The application of optical
coherence tomography angiography in cerebral small vessel disease, ischemic
stroke and dementia: a systematic review</article-title>. <source>Front
Neurol</source><year>2020</year>; <volume>11</volume>: <fpage>1009</fpage>.<pub-id pub-id-type="pmid">33013667</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2020.01009</pub-id><pub-id pub-id-type="pmcid">PMC7511809</pub-id></mixed-citation></ref><ref id="bibr18-0271678X221135658"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clancy</surname><given-names>U</given-names></name><name name-style="western"><surname>Jaime Garcia</surname><given-names>D</given-names></name><name name-style="western"><surname>Stringer</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Rational and design of a
longitudinal study of cerebral small vessel diseases, clinical, and imaging
outcomes in patients presenting with mild ischaemic stroke: Mild Stroke
Study 3 (MSS-3</article-title>). <source>Eur Stroke J</source><year>2021</year>; <volume>6</volume>:
<fpage>81</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">33817338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2396987320929617</pub-id><pub-id pub-id-type="pmcid">PMC7995323</pub-id></mixed-citation></ref><ref id="bibr19-0271678X221135658"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fazekas</surname><given-names>F</given-names></name><name name-style="western"><surname>Chawluk</surname><given-names>JB</given-names></name><name name-style="western"><surname>Alavi</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>MR signal abnormalities at
1.5 T in Alzheimer’ s dementia and normal aging</article-title>. <source>AJR
Am J Roentgenol</source><year>1987</year>; <volume>149</volume>:
<fpage>351</fpage>–<lpage>356</lpage>.<pub-id pub-id-type="pmid">3496763</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2214/ajr.149.2.351</pub-id></mixed-citation></ref><ref id="bibr20-0271678X221135658"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Potter</surname><given-names>GM</given-names></name><name name-style="western"><surname>Chappell</surname><given-names>FM</given-names></name><name name-style="western"><surname>Morris</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal>. <article-title>Cerebral perivascular spaces
visible on magnetic resonance imaging: development of a qualitative rating
scale and its observer reliability</article-title>. <source>Cerebrovasc
Dis</source><year>2015</year>; <volume>39</volume>:
<fpage>224</fpage>–<lpage>231</lpage>.<pub-id pub-id-type="pmid">25823458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000375153</pub-id><pub-id pub-id-type="pmcid">PMC4386144</pub-id></mixed-citation></ref><ref id="bibr21-0271678X221135658"><label>21</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Potter</surname><given-names>G</given-names></name><name name-style="western"><surname>Morris</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wardlaw</surname><given-names>J.</given-names></name></person-group> Enlarged perivascular spaces (EPVS): a visual rating scale and
user guide, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ed.ac.uk/files/imports/fileManager/epvs-rating-scale-user-guide.pdf" ext-link-type="uri">www.ed.ac.uk/files/imports/fileManager/epvs-rating-scale-user-guide.pdf</ext-link>
(accessed 23 January <year>2020</year>).</mixed-citation></ref><ref id="bibr22-0271678X221135658"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Bannister</surname><given-names>P</given-names></name><name name-style="western"><surname>Brady</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Improved optimisation for
the robust and accurate linear registration and motion correction of brain
images</article-title>. <source>NeuroImage</source><year>2002</year>; <volume>17</volume>:
<fpage>825</fpage>–<lpage>841</lpage>.<pub-id pub-id-type="pmid">12377157</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1053-8119(02)91132-8</pub-id></mixed-citation></ref><ref id="bibr23-0271678X221135658"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Brady</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S.</given-names></name></person-group><article-title>Segmentation of brain MR images through a hidden Markov random
field model and the expectation-maximization algorithm</article-title>.
<source>IEEE Trans Med Imaging</source><year>2001</year>; <volume>20</volume>:
<fpage>45</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">11293691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/42.906424</pub-id></mixed-citation></ref><ref id="bibr24-0271678X221135658"><label>24</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Pechaud</surname><given-names>M</given-names></name><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S.</given-names></name></person-group> BET2 – MRI-based estimation of brain, skull and scalp surfaces.
<italic toggle="yes">FMRIB Tech Rep TR06MP1.</italic> 206AD, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.fmrib.ox.ac.uk/datasets/techrep/tr06mp1/tr06mp1.pdf" ext-link-type="uri">www.fmrib.ox.ac.uk/datasets/techrep/tr06mp1/tr06mp1.pdf</ext-link>
(accessed 20 December 2020).</mixed-citation></ref><ref id="bibr25-0271678X221135658"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Thrippleton</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Blair</surname><given-names>GW</given-names></name></person-group>, <etal>et al</etal>. <article-title>Small vessel disease is
associated with altered cerebrovascular pulsatility but not resting cerebral
blood flow</article-title>. <source>J Cereb Blood Flow Metab</source><year>2020</year>; <volume>40</volume>:
<fpage>85</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">30295558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0271678X18803956</pub-id><pub-id pub-id-type="pmcid">PMC6928551</pub-id></mixed-citation></ref><ref id="bibr26-0271678X221135658"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walker</surname><given-names>PG</given-names></name><name name-style="western"><surname>Cranney</surname><given-names>GB</given-names></name><name name-style="western"><surname>Scheideggar</surname><given-names>MB</given-names></name></person-group>, <etal>et al</etal>. <article-title>Semiautomated method for
noise reduction and background phase error correction in MR phase velocity
data</article-title>. <source>J Mag Res Imaging</source><year>1993</year>; <volume>3</volume>:
<fpage>521</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmri.1880030315</pub-id><pub-id pub-id-type="pmid">8324312</pub-id></mixed-citation></ref><ref id="bibr27-0271678X221135658"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sleight</surname><given-names>E</given-names></name><name name-style="western"><surname>Stringer</surname><given-names>MS</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>I</given-names></name></person-group>, <etal>et al</etal>. <article-title>Cerebrovascular reactivity
measurement using magnetic resonance imaging: a systematic
review</article-title>. <source>Front Physiol</source><year>2021</year>; <volume>12</volume>: <fpage>643468</fpage>.<pub-id pub-id-type="pmid">33716793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphys.2021.643468</pub-id><pub-id pub-id-type="pmcid">PMC7947694</pub-id></mixed-citation></ref><ref id="bibr28-0271678X221135658"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blair</surname><given-names>GW</given-names></name><name name-style="western"><surname>Thrippleton</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name></person-group>, <etal>et al</etal>. <article-title>Intracranial hemodynamic
relationships in patients with cerebral small vessel
disease</article-title>. <source>Neurology</source><year>2020</year>; <volume>94</volume>:
<fpage>e2258</fpage>–<lpage>e2269</lpage>.<pub-id pub-id-type="pmid">32366534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000009483</pub-id><pub-id pub-id-type="pmcid">PMC7357294</pub-id></mixed-citation></ref><ref id="bibr29-0271678X221135658"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blair</surname><given-names>GW</given-names></name><name name-style="western"><surname>Doubal</surname><given-names>FN</given-names></name><name name-style="western"><surname>Thrippleton</surname><given-names>MJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Magnetic resonance imaging
for assessment of cerebrovascular reactivity in cerebral small vessel
disease: a systematic review</article-title>. <source>J Cereb Blood Flow
Metab</source><year>2016</year>; <volume>36</volume>:
<fpage>833</fpage>–<lpage>841</lpage>.<pub-id pub-id-type="pmid">26884471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0271678X16631756</pub-id><pub-id pub-id-type="pmcid">PMC4853842</pub-id></mixed-citation></ref><ref id="bibr30-0271678X221135658"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gadde</surname><given-names>SGK</given-names></name><name name-style="western"><surname>Anegondi</surname><given-names>N</given-names></name><name name-style="western"><surname>Bhanushali</surname><given-names>D</given-names></name></person-group>, <etal>et al</etal>. <article-title>Quantification of vessel
density in retinal optical coherence tomography angiography images using
local fractal dimension</article-title>. <source>Invest Ophthalmol Vis
Sci</source><year>2016</year>; <volume>57</volume>:
<fpage>246</fpage>–<lpage>252</lpage>.<pub-id pub-id-type="pmid">26803800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.15-18287</pub-id></mixed-citation></ref><ref id="bibr31-0271678X221135658"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lemmens</surname><given-names>S</given-names></name><name name-style="western"><surname>Devulder</surname><given-names>AV</given-names></name><name name-style="western"><surname>Keer</surname><given-names>K</given-names></name></person-group>, <etal>et al</etal>. <article-title>Systematic review on fractal
dimension of the retinal vasculature in neurodegeneration and stroke:
assessment of a potential biomarker</article-title>. <source>Front
Neurosci</source><year>2020</year>; <volume>14</volume>: <fpage>16</fpage>.<pub-id pub-id-type="pmid">32116491</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnins.2020.00016</pub-id><pub-id pub-id-type="pmcid">PMC7025576</pub-id></mixed-citation></ref><ref id="bibr32-0271678X221135658"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stošić</surname><given-names>T</given-names></name><name name-style="western"><surname>Stošić</surname><given-names>BD.</given-names></name></person-group><article-title>Multifractal analysis of human retinal vessels</article-title>.
<source>IEEE Trans Med Imaging</source><year>2006</year>; <volume>25</volume>:
<fpage>1101</fpage>–<lpage>1107</lpage>.<pub-id pub-id-type="pmid">16895002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1109/tmi.2006.879316</pub-id></mixed-citation></ref><ref id="bibr33-0271678X221135658"><label>33</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>J-H</given-names></name><name name-style="western"><surname>Ong</surname><given-names>S-H</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name></person-group> Morphometric measurements of the retinal vasculature in fundus
images with VAMPIRE (Chapter 3). In: <italic toggle="yes">Biomedical image understanding:
methods and applications</italic>. Hoboken, NJ: Wiley, <year>2015</year>,
pp. 91–111.</mixed-citation></ref><ref id="bibr34-0271678X221135658"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koo</surname><given-names>TK</given-names></name><name name-style="western"><surname>Li</surname><given-names>MY.</given-names></name></person-group><article-title>A guideline of selecting and reporting intraclass correlation
coefficients for reliability research</article-title>. <source>J Chiropr
Med</source><year>2016</year>; <volume>15</volume>:
<fpage>155</fpage>–<lpage>163</lpage>.<pub-id pub-id-type="pmid">27330520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcm.2016.02.012</pub-id><pub-id pub-id-type="pmcid">PMC4913118</pub-id></mixed-citation></ref><ref id="bibr35-0271678X221135658"><label>35</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Gamer</surname><given-names>M</given-names></name><name name-style="western"><surname>Lemon</surname><given-names>J</given-names></name><name name-style="western"><surname>Fellows</surname><given-names>I</given-names></name></person-group>, <etal>et al</etal>. irr: various coefficients of interrater
reliability and agreement. R package version 0.84, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://CRAN.R-project.org/package=irr" ext-link-type="uri">https://CRAN.R-project.org/package=irr</ext-link> (accessed 15 March
2021).</mixed-citation></ref><ref id="bibr36-0271678X221135658"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cameron</surname><given-names>JR</given-names></name><name name-style="western"><surname>Megaw</surname><given-names>RD</given-names></name><name name-style="western"><surname>Tatham</surname><given-names>AJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Lateral thinking –
interocular symmetry and asymmetry in neurovascular patterning, in health
and disease</article-title>. <source>Prog Retin Eye Res</source><year>2017</year>; <volume>59</volume>:
<fpage>131</fpage>–<lpage>157</lpage>.<pub-id pub-id-type="pmid">28457789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.preteyeres.2017.04.003</pub-id></mixed-citation></ref><ref id="bibr37-0271678X221135658"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sam</surname><given-names>K</given-names></name><name name-style="western"><surname>Conklin</surname><given-names>J</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>KR</given-names></name></person-group>, <etal>et al</etal>. <article-title>Impaired dynamic
cerebrovascular response to hypercapnia predicts development of white matter
hyperintensities</article-title>. <source>NeuroImage Clin</source><year>2016</year>; <volume>11</volume>:
<fpage>796</fpage>–<lpage>801</lpage>.<pub-id pub-id-type="pmid">27358765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nicl.2016.05.008</pub-id><pub-id pub-id-type="pmcid">PMC4917393</pub-id></mixed-citation></ref><ref id="bibr38-0271678X221135658"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atwi</surname><given-names>S</given-names></name><name name-style="western"><surname>Shao</surname><given-names>H</given-names></name><name name-style="western"><surname>Crane</surname><given-names>DE</given-names></name></person-group>, <etal>et al</etal>. <article-title>BOLD-based cerebrovascular
reactivity vascular transfer function isolates amplitude and timing
responses to better characterize cerebral small vessel
disease</article-title>. <source>NMR Biomed</source><year>2019</year>; <volume>32</volume>:
<fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nbm.4064</pub-id><pub-id pub-id-type="pmid">30693582</pub-id></mixed-citation></ref><ref id="bibr39-0271678X221135658"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashimatey</surname><given-names>BS</given-names></name><name name-style="western"><surname>D’Orazio</surname><given-names>LM</given-names></name><name name-style="western"><surname>Ma</surname><given-names>SJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Lower retinal capillary
density in minimal cognitive impairment among older latinx
adults</article-title>. <source>Alzheimers Dement (Amst)</source><year>2020</year>; <volume>12</volume>:
<fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/dad2.12071</pub-id><pub-id pub-id-type="pmcid">PMC7447879</pub-id><pub-id pub-id-type="pmid">32875053</pub-id></mixed-citation></ref><ref id="bibr40-0271678X221135658"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maniega</surname><given-names>SM</given-names></name><name name-style="western"><surname>Valdés Hernández</surname><given-names>MC</given-names></name><name name-style="western"><surname>Clayden</surname><given-names>JD</given-names></name></person-group>, <etal>et al</etal>. <article-title>White matter
hyperintensities and normal-appearing white matter integrity in the aging
brain</article-title>. <source>Neurobiol Aging</source><year>2015</year>; <volume>36</volume>:
<fpage>909</fpage>–<lpage>918</lpage>.<pub-id pub-id-type="pmid">25457555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neurobiolaging.2014.07.048</pub-id><pub-id pub-id-type="pmcid">PMC4321830</pub-id></mixed-citation></ref><ref id="bibr41-0271678X221135658"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wardlaw</surname><given-names>JM</given-names></name><name name-style="western"><surname>Benveniste</surname><given-names>H</given-names></name><name name-style="western"><surname>Nedergaard</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Perivascular spaces in the
brain: anatomy, physiology and pathology</article-title>. <source>Nat Rev
Neurol</source><year>2020</year>; <volume>16</volume>:
<fpage>137</fpage>–<lpage>153</lpage>.<pub-id pub-id-type="pmid">32094487</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41582-020-0312-z</pub-id></mixed-citation></ref><ref id="bibr42-0271678X221135658"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mutlu</surname><given-names>U</given-names></name><name name-style="western"><surname>Adams</surname><given-names>HHH</given-names></name><name name-style="western"><surname>Hofman</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Retinal microvascular
calibers are associated with enlarged perivascular spaces in the
brain</article-title>. <source>Stroke</source><year>2016</year>; <volume>47</volume>:
<fpage>1374</fpage>–<lpage>1376</lpage>.<pub-id pub-id-type="pmid">26979867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.115.012438</pub-id></mixed-citation></ref><ref id="bibr43-0271678X221135658"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossitti</surname><given-names>S</given-names></name><name name-style="western"><surname>Frisen</surname><given-names>L.</given-names></name></person-group><article-title>Remodelling of the retinal arterioles in descending optic atrophy
follows the principle of minimum work</article-title>. <source>Acta Physiol
Scand</source><year>1994</year>; <volume>152</volume>:
<fpage>333</fpage>–<lpage>340</lpage>.<pub-id pub-id-type="pmid">7872010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1748-1716.1994.tb09813.x</pub-id></mixed-citation></ref><ref id="bibr44-0271678X221135658"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name></person-group>, <etal>et al</etal>. <article-title>The vessel density of the
superficial retinal capillary plexus as a new biomarker in cerebral small
vessel disease: an optical coherence tomography angiography
study</article-title>. <source>Neurol Sci</source><year>2021</year>; <volume>42</volume>:
<fpage>3615</fpage>–<lpage>3624</lpage>.<pub-id pub-id-type="pmid">33432462</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10072-021-05038-z</pub-id></mixed-citation></ref><ref id="bibr45-0271678X221135658"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tao</surname><given-names>R</given-names></name></person-group>, <etal>et al</etal>. <article-title>Decreased retinal vascular
density in Alzheimer’s disease (AD) and mild cognitive impairment (MCI): an
optical coherence tomography angiography (OCTA) study</article-title>.
<source>Front Aging Neurosci</source><year>2020</year>; <volume>12</volume>: <fpage>572484</fpage>.<pub-id pub-id-type="pmid">33519415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnagi.2020.572484</pub-id><pub-id pub-id-type="pmcid">PMC7843508</pub-id></mixed-citation></ref><ref id="bibr46-0271678X221135658"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Courtie</surname><given-names>EF</given-names></name><name name-style="western"><surname>Kale</surname><given-names>AU</given-names></name><name name-style="western"><surname>Hui</surname><given-names>BTK</given-names></name></person-group>, <etal>et al</etal>. <article-title>Stability of OCT and OCTA in
the intensive therapy unit setting</article-title>.
<source>Diagnostics</source><year>2021</year>; <volume>11</volume>: <fpage>1516</fpage>.<pub-id pub-id-type="pmid">34441449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics11081516</pub-id><pub-id pub-id-type="pmcid">PMC8394026</pub-id></mixed-citation></ref><ref id="bibr47-0271678X221135658"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>CR</given-names></name><name name-style="western"><surname>Stringer</surname><given-names>MS</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name></person-group>, <etal>et al</etal>. <article-title>Associations between white
matter hyperintensity burden, cerebral blood flow and transit time in small
vessel disease: an updated meta-analysis</article-title>. <source>Front
Neurol</source><year>2021</year>; <volume>12</volume>: <fpage>647848</fpage>.<pub-id pub-id-type="pmid">34017302</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2021.647848</pub-id><pub-id pub-id-type="pmcid">PMC8129542</pub-id></mixed-citation></ref></ref-list></back></article>